OpenVSafe by OpenVAERS
Search V-safe

R6Q-32103-29223

1 vaccination 2 coded responses 12 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
763 / TX
Registered
2021-08-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-08-12
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-08-13
    Registered in v-safe
  3. 2021-08-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Nausea
    Adult check-in
  4. 2021-08-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-08-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-08-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-08-19
    Health check-in — day 7, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  8. 2021-08-26
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-09-04
    Survey response — day 21, single dose
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Exhaustion
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  10. 2021-09-18
    Health check-in — day 35, single dose
    Feeling: Fair
    Adult check-in
  11. 2021-09-25
    Health check-in — day 42, single dose
    Feeling: Good
    Adult check-in
  12. 2021-11-12
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  13. 2022-02-12
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  14. 2022-08-14
    Survey response — 12 months, dose 1
    MedDRA: Thyroiditis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Thyroiditis, maybe SAT
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-08-14
    Report sent to call center — 12 months, dose 1
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  16. 2022-08-15
  17. 2022-08-18
  18. 2022-08-19

Vaccinations

DoseDateManufacturerCo-administered
12021-08-12Janssen/Johnson & Johnson No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — day 21, single dose

2021-09-04

Symptoms: Exhaustion

Release 12 — 12 months, dose 1

2022-08-14

Symptoms: Thyroiditis, maybe SAT

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue ✓ · ✓
SDThyroiditis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release